Wegovy (semaglutide) and sotrovimab will soon be available.

A new 500mg injection will soon be available.

A novel bupivacaine formulation works as a 72-hour local anesthetic following shoulder surgery.

Veklury is approved for hospitalized patients, while bamlanivimab is being investigated in mild-to-moderate cases of COVID-19.

Olinvyk injections and Qdolo oral solution are approved for the management of acute pain.

A biosimilar to Humira is approved, the FDA Fast Tracks a PTSD drug, and more.

Cassipa (buprenorphine and naloxone) sublingual film delivers a new dosage for the treatment of opioid dependence.

The FDA recently approved drugs to treat opioid dependence, migraines, and rheumatoid arthritis.